查看所有供应商和价格请点击:
1621999-82-3生产厂家
1621999-82-3价格
化源商城直购
ERK1
ERK2
[1]. Monica M. Mita, et al. A phase Ia study of CC-90003, a selective extracellular signal-regulated kinase (ERK) inhibitor, in patients with relapsed or refractory BRAF or RAS-mutant tumors. Journal of Clinical Oncology 35, no. 15_suppl (May 20 2017) 2577-2577.